SCHEMBL4173787

SCHEMBL4173787

Cc1cc(C)c(S(=O)(=O)N[C@H]2CCN(c3cccc4ncccc34)C2)c(C)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 5/20 0.59
SLC40A1 Q9NP59 1/20 0.41
AKT1 P31749 1/20 0.40
KEAP1 Q14145 1/20 0.40
HTR1A P08908 2/20 0.40
HTR7 P34969 2/20 0.40
DRD2 P14416 1/20 0.40
HTR6 P50406 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
RAPGEF4 Q8WZA2 1/20 0.38
BRD4 O60885 1/20 0.37
NR3C2 P08235 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
HTT P42858 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
PDE10A Q9Y233 1/20 0.37
SMO Q99835 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5603836 0.95 NR3C1 (0.55) NR3C1SLC40A1AKT1KEAP1HTR1A
SCHEMBL4175480 0.89 NR3C1 (0.48) NR3C1AKT1KEAP1HTR1AHTR7
SCHEMBL4169959 0.88 NR3C1 (0.50) NR3C1AKT1KEAP1HTR1AHTR7
SCHEMBL4168032 0.84 NR3C1 (0.46) NR3C1SLC40A1HTR1AHTR7DRD2
SCHEMBL4175573 0.82 NR3C1 (0.43) NR3C1AKT1KEAP1HTR1AHTR7
SCHEMBL4170944 0.81 NR3C1 (0.42) NR3C1AKT1KEAP1HTR1AHTR7
SCHEMBL14403931 0.80 NR3C1 (0.42) NR3C1KEAP1HTR1AHTR7DRD2
SCHEMBL4163578 0.77 NR3C1 (0.48) NR3C1AKT1HTR1AHTR7DRD2
SCHEMBL14404036 0.77 NR3C1 (0.48) NR3C1AKT1HTR1AHTR7DRD2
SCHEMBL4163672 0.76 MTNR1A (0.44) DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090170898-A1 Sulphonamide Derivatives as Modulators of the Glucocorticoid Receptor BENGTSSON MALENA 2009-07-02 US disclosed
US-20090170898-A1 Sulphonamide Derivatives as Modulators of the Glucocorticoid Receptor BENGTSSON MALENA 2009-07-02 US disclosed
US-20090170898-A1 Sulphonamide Derivatives as Modulators of the Glucocorticoid Receptor BENGTSSON MALENA 2009-07-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090170898-A1 Sulphonamide Derivatives as Modulators of the Glucocorticoid Receptor NR3C1, NR3C2, NR5A1 NR3C1 1/4885SLC40A1 2238/4885AKT1 3899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.